Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07282067 · ClinicalTrials.gov registry record
Orthofix PhysioStim PEMF Ankle Fusion Retrospective
A clinical trial of Ankle Fusion and Hindfoot Arthrodesis, sponsored by Orthofix.
- Active
- Registry status
- 200
- Enrollment target
- 8
- Study locations
NCT07282067: Active study of Ankle Fusion and Hindfoot Arthrodesis, sponsored by Orthofix.
NCT07282067 is a study of Ankle Fusion and Hindfoot Arthrodesis that is active but no longer recruiting, run by Orthofix. The registered enrollment target is 200 participants. The trial reports 8 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07282067, a study of Ankle Fusion and Hindfoot Arthrodesis, is active but no longer recruiting, sponsored by Orthofix.
- ACTIVE NOT RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 8
- Study locations
Study Summary
This study examines the effect of using the PhysioStim bone growth stimulator on subjects undergoing treatment for ankle and hindfoot fusion surgery.
Primary Outcome
Fusion rate (# subjects fused / # total evaluable subjects) based on radiographic assessment.
Conditions Studied
Interventions
- OTHER Control
- DEVICE Pulsed electromagnetic field (PEMF) stimulation
Study Locations (8)
Arizona
- Arizona Foot Health - Phoenix
- Phoenix Foot and Ankle Institute - Scottsdale
- OrthoArizona - Scottsdale
California
- Byron COllier DPM, Inc - Pismo Beach
Iowa
- East Village Foot and Ankle - Des Moines
Maryland
- Precision Orthopedics and Sports Medicine - Laurel
North Carolina
- OrthoCarolina Research Institute, Inc - Charlotte
Texas
- Lone Star Orthopaedic and Spine Specialists - Fort Worth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-01-23 |
| Est. Completion | 2026-03 |
What the registry record for NCT07282067 still lists
NCT07282067 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 4 conditions, with Ankle Fusion appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.
NCT07282067 lists 8 locations in 6 states (Arizona, California, Iowa).
Frequently Asked Questions
What is clinical trial NCT07282067 about?
NCT07282067 is a clinical study titled "Orthofix PhysioStim PEMF Ankle Fusion Retrospective". This study examines the effect of using the PhysioStim bone growth stimulator on subjects undergoing treatment for ankle and hindfoot fusion surgery.
What is the current status of trial NCT07282067?
This trial is currently active not recruiting. The enrollment target is 200 participants. The study started on 2025-01-23. Estimated completion is 2026-03.
What conditions does trial NCT07282067 study?
This clinical trial studies the following conditions: Ankle Fusion, Hindfoot Arthrodesis, Ankle Arthrodesis, Tibiotalar Arthrodesis.
What interventions are being tested in trial NCT07282067?
The interventions under investigation include: Control (OTHER), Pulsed electromagnetic field (PEMF) stimulation (DEVICE).
Who is sponsoring clinical trial NCT07282067?
This trial is sponsored by Orthofix, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07282067 being conducted?
This trial has 8 study locations across Arizona, California, Iowa, Maryland, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ankle Fusion
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI